Jankovic J, Tan EK. Parkinson’s disease: etiopathogenesis and treatment. J Neurol Neurosurg Psychiatry. 2020;91:795–808.
Li T, Le W. Biomarkers for Parkinson’s Disease: how good are they? Neurosci Bull. 2020;36:183–94.
Article CAS PubMed Google Scholar
Wang Y, Chen X, Wang Y, Li S, Cai H, Le W. The essential role of transcription factor Pitx3 in preventing mesodiencephalic dopaminergic neurodegeneration and maintaining neuronal subtype identities during aging. Cell Death Dis. 2021;12:1008.
Article PubMed PubMed Central Google Scholar
Bendig J, Frank A, Reichmann H. Aging and Parkinson’s disease: a complex interplay of vulnerable neurons, the immune system and the blood-brain barrier. Ageing Neurodegenerative Dis. 2024;4:5.
Schapira AHV, Chaudhuri KR, Jenner P. Non-motor features of Parkinson disease. Nat Rev Neurosci. 2017;18:509.
Article CAS PubMed Google Scholar
Hu Y, Liang Z, Song C. Electroneurography abnormality in Parkinson’s disease: a potential biomarker to help diagnosis. Ageing Neurodegenerative Dis. 2022;2:9.
Li T, Le W, Jankovic J. Linking the cerebellum to Parkinson disease: an update. Nat Rev Neurol. 2023;19:645–54.
Wu T, Hallett M. The cerebellum in Parkinson’s disease. Brain. 2013;136:696–709.
Article PubMed PubMed Central Google Scholar
Qiu T, Li T, Le W. Cerebellar involvement in Parkinson’s disease: pathophysiology and neuroimaging. Chin Med J (Engl). 2024;137:2395–403.
Article CAS PubMed Google Scholar
Seidel K, Bouzrou M, Heidemann N, Kruger R, Schols L, den Dunnen WFA, Korf HW, Rub U. Involvement of the cerebellum in Parkinson disease and dementia with Lewy bodies. Ann Neurol. 2017;81:898–903.
Article CAS PubMed Google Scholar
Riou A, Houvenaghel JF, Dondaine T, Drapier S, Sauleau P, Drapier D, Duprez J, Guillery M, Le Jeune F, Verin M, Robert G. Functional role of the Cerebellum in Parkinson Disease: a PET study. Neurology. 2021;96:e2874–84.
O’Callaghan C, Hornberger M, Balsters JH, Halliday GM, Lewis SJ, Shine JM. Cerebellar atrophy in Parkinson’s disease and its implication for network connectivity. Brain. 2016;139:845–55.
Huang EP, O’Connor JPB, McShane LM, Giger ML, Lambin P, Kinahan PE, Siegel EL, Shankar LK. Criteria for the translation of radiomics into clinically useful tests. Nat Rev Clin Oncol. 2023;20:69–82.
Zhao K, Zheng Q, Dyrba M, Rittman T, Li A, Che T, Chen P, Sun Y, Kang X, Li Q, et al. Regional Radiomics Similarity Networks reveal distinct subtypes and abnormality patterns in mild cognitive impairment. Adv Sci (Weinh). 2022;9:e2104538.
Chen YN, Qi YW, Hu YY, Qiu XH, Qiu T, Li S, Liu MC, Jia QQ, Sun B, Liu C, Li T, Le WD. Integrated cerebellar radiomic-network model for predicting mild cognitive impairment in Alzheimer’s disease. Alzheimers Dement. 2024;21:e14361. https://doi.org/10.1002/alz.14361
Article PubMed PubMed Central Google Scholar
Park CJ, Eom J, Park KS, Park YW, Chung SJ, Kim YJ, Ahn SS, Kim J, Lee PH, Sohn YH, Lee SK. An interpretable multiparametric radiomics model of basal ganglia to predict dementia conversion in Parkinson’s disease. NPJ Parkinsons Dis. 2023;9:127.
Article CAS PubMed PubMed Central Google Scholar
Guan XJ, Guo T, Zhou C, Gao T, Wu JJ, Han V, Cao S, Wei HJ, Zhang YY, Xuan M, et al. A multiple-tissue-specific magnetic resonance imaging model for diagnosing Parkinson’s disease: a brain radiomics study. Neural Regen Res. 2022;17:2743–9.
Article PubMed PubMed Central Google Scholar
Pan P, Zhan H, Xia M, Zhang Y, Guan D, Xu Y. Aberrant regional homogeneity in Parkinson’s disease: a voxel-wise meta-analysis of resting-state functional magnetic resonance imaging studies. Neurosci Biobehav Rev. 2017;72:223–31.
Hacker CD, Perlmutter JS, Criswell SR, Ances BM, Snyder AZ. Resting state functional connectivity of the striatum in Parkinson’s disease. Brain. 2012;135:3699–711.
Article PubMed PubMed Central Google Scholar
Kawabata K, Watanabe H, Bagarinao E, Ohdake R, Hara K, Ogura A, Masuda M, Kato T, Tsuboi T, Maesawa S, et al. Cerebello-basal ganglia connectivity fingerprints related to motor/cognitive performance in Parkinson’s disease. Parkinsonism Relat Disord. 2020;80:21–7.
Piccinin CC, Campos LS, Guimaraes RP, Piovesana LG, Dos Santos MCA, Azevedo PC, Campos BM, de Rezende TJR, Amato-Filho A, Cendes F, D’Abreu A. Differential Pattern of Cerebellar Atrophy in Tremor-Predominant and Akinetic/Rigidity-Predominant Parkinson’s Disease. Cerebellum. 2017;16:623–8.
Kerestes R, Laansma MA, Owens-Walton C, Perry A, van Heese EM, Al-Bachari S, Anderson TJ, Assogna F, Aventurato IK, van Balkom TD, et al. Cerebellar volume and Disease staging in Parkinson’s Disease: an ENIGMA-PD study. Mov Disord. 2023;38:2269–81.
Article CAS PubMed PubMed Central Google Scholar
Adeli E, Wu G, Saghafi B, An L, Shi F, Shen D. Kernel-based Joint Feature Selection and Max-Margin classification for early diagnosis of Parkinson’s Disease. Sci Rep. 2017;7:41069.
Article CAS PubMed PubMed Central Google Scholar
Liu H, Du G, Zhang L, Lewis MM, Wang X, Yao T, Li R, Huang X. Folded concave penalized learning in identifying multimodal MRI marker for Parkinson’s disease. J Neurosci Methods. 2016;268:1–6.
Article PubMed PubMed Central Google Scholar
Long D, Wang J, Xuan M, Gu Q, Xu X, Kong D, Zhang M. Automatic classification of early Parkinson’s disease with multi-modal MR imaging. PLoS ONE. 2012;7:e47714.
Article CAS PubMed PubMed Central Google Scholar
Suo X, Lei D, Li W, Li L, Dai J, Wang S, Li N, Cheng L, Peng R, Kemp GJ, Gong Q. Altered white matter microarchitecture in Parkinson’s disease: a voxel-based meta-analysis of diffusion tensor imaging studies. Front Med. 2021;15:125–38.
Comments (0)